nipro corp (8086:Tokyo)
Transactions by NIPRO CORP (8086) in the last 6 months
Dongduk Medical Corporation announced that it will receive KRW 2 billion in an equity round of funding from new investor, Nipro Corporation on December 3, 2014. The transaction is by way of third party capital increase in the company. As part of the transaction, the investor will acquire 33.33% stake in the company. On closing of the investment, the name of the company will change to Nipro Dongduk Medical Corporation.
Nipro Corporation (TSE:8086) agreed to acquire the remaining 48.33% stake in Cell Science & Technology Institute, Inc. from MEDINET Co., Ltd. (TSE:2370), Funakoshi Co.,Ltd. and Takeshi Sato for approximately ¥210 million on November 21, 2014. For every 90 shares of NIPRO Corp will swap one share of Cell Science & Technology Institute, Inc. Nipro will furnish 0.21 million common shares (tentative) for the share exchange. The shares to be allocated will be held treasury ...
MEDINET Co., Ltd.
Nipro Corporation (TSE:8086) signed a share transfer contract to acquire 51% stake in Rigi Medizintechnik GmbH from CVBC Investment Holding AG on August 1, 2014. Impact on NIPRO’s performance result is minimal.
|Dr Reddy's Laboratories Ltd||3,233 INR||-130.05|
|JMS Co Ltd||¥289.00 JPY||+2.00|
|Nikkiso Co Ltd||¥1,043 JPY||+19.00|
|NxStage Medical Inc||$17.89 USD||-0.58|
|Taro Pharmaceutical Industries Ltd||$166.50 USD||+0.51|
|View Industry Companies|